ABSTRACT: Indirect evidence suggests that in the subependymal layer (SEL) steroid hormones could be partially involved in the modulation of neurogenesis, but little or nothing is known about a direct effect of these molecules on this cellular system. The possible effect of progesterone (P) and/or its neuroactive metabolites, dihydroprogesterone (DHP) and tetrahydroprogesterone (THP), on the two cellular components of the SEL (i.e., proliferating/migrating neuroblasts and protoplasmic astrocytes) has been analyzed in adult male rat. P, DHP, and THP were administered by intraventricular injections and after 2 days the SEL was analyzed by immunohistochemistry by using anti-glial fibrillary acidic protein (GFAP) and anti-vimentin antibodies, to label the glial compartment, anti-polysialylated form of the neural cell adhesion molecule (PSA-NCAM), anti-Stathmin, and anti-␤ III Tubulin antibodies to label the migrating neuroblasts. Furthermore, the newly formed cells were identified by using intraventricular injections of 5-bromo-2-deoxyuridine (BrdU) detected immunohistochemically. Our results demonstrate that DHP and THP treatments drastically decrease the number of BrdUlabeled cells within the SEL. THP, DHP, and to a lesser extent P, administrations also induce molecular and structural modifications of the SEL glial compartment. On the whole, the present results indicate that neuroactive derivatives of P (i.e., DHP and THP) exert direct effects on adult neurogenesis, strongly affecting both neuroblasts and astrocytes of the SEL.
INTRODUCTION
The genesis of new neurons in the major part of the brain usually corresponds to a well-defined developmental period. However, in specific areas of the adult mammalian central nervous system, such as the subependymal layer (SEL) of the rostral forebrain and the dentate gyrus of the hippocampus, neurogenesis is protracted virtually throughout life (Altman and Das, 1965; Altman, 1969; Cameron et al., 1993; Luskin, 1993; Lois and Alvarez-Buylla, 1994) . Light and electron microscopy studies have demonstrated the existence of two cellular compartments within the SEL: 1) chains of proliferating/migrating neuroblasts expressing the embryonic polysialylated form of the neural cell adhesion molecule (PSA-NCAM) (Bonfanti and Theodosis, 1994; Rousselot et al., 1995) ; 2) protoplasmic astrocytes that give rise to a channel system (glial tubes) that separates the chains of proliferating/migrating cells from the surrounding mature tissue (Jankowski and Sotelo, 1996; Lois et al., 1996; Peretto et al., 1997) . SEL astroglia shows peculiar characteristics and may play a crucial role in creating a permissive environment (niche) for adult neurogenesis (Jankowski and Sotelo, 1996; Lim et al., 2000; Coskun et al., 2001; Peretto et al., 2002) . Throughout life, the SEL provides a continuous supply of newly formed cells that, after long tangential migration within the SEL rostral extension (SEL-RE), reach the olfactory bulb (OB) and differentiate into interneurons (Luskin, 1993) within the granular and glomerular layers (Lois and Alvarez-Buylla, 1994) .
Several studies carried out over the last few years have shown that the proliferation and survival of newly generated granule cells in the adult hippocampus are modulated by diverse environmental Van Praag et al., 1999) and hormonal factors (Gould et al., 1992; Cameron and Gould, 1994; Tanapat et al., 1999) . In particular, it has been shown that steroid hormones can act on adult hippocampal neurogenesis by modulating cell proliferation (Gould et al., 1992; Cameron and Gould, 1994; Tanapat et al., 1999) . Within the SEL it has been demonstrated that estrogens may be responsible, at least in part, for the increased proliferation observed during estrus induction in the prairie vole (Smith et al., 2001) . Furthermore, migrating neuroblasts of the SEL rostral migratory stream also reach the rat accessory olfactory bulb (AOB) . The AOB is a well known sexually dimorphic structure that develops under the control of sexual steroids and shows, during adulthood, a sexually dimorphic distribution of the rostral migratory stream neuroblasts within its anterior part (Peretto et al., 2001) . Even if this indirect evidence suggests that steroid hormones could be involved in the modulation of adult neurogenesis in the SEL (Smith et al., 2001) , little or nothing is known about a direct effect of these molecules on this cellular system.
The central nervous system contains the enzymes involved in the synthesis of a variety of steroids, forming the so-called neurosteroids (Baulieu, 1998; Compagnone and Mellon, 2000; Melcangi and Panzica, 2001; Mellon et al., 2001) . Moreover, the nervous system is able to convert neurosteroids, or hormonal steroids coming from the periphery, in metabolites called neuroactive steroids (Melcangi et al., 1999 (Melcangi et al., , 2001a Melcangi and Panzica, 2001 ). For instance, progesterone (P), which is also synthesized in the nervous system (Compagnone and Mellon, 2000; Mellon et al., 2001) , may be further 5␣-reduced into dihydroprogesterone (DHP) and subsequently 3␣-hydroxylated into tetrahydroprogesterone (THP), respectively via the enzymes 5␣-reductase (5␣-R) and 3␣-hydroxysteroid dehydrogenase (3␣-HSD) (Melcangi et al., 1999 (Melcangi et al., , 2001a . Interestingly, at least in vitro, P and its metabolites seem to be able to influence the glial compartment of the SEL (i.e., protoplasmic astrocytes). Utilizing a primary culture of type 1 astrocytes, which probably in vitro correspond to protoplasmic astrocytes present in vivo, we have previously demonstrated that P, DHP, and THP can modulate the gene expression of glial fibrillary acidic protein (GFAP) (Melcangi et al., 1996b) . Consequently, in this work we have analyzed whether P and its metabolites (i.e., DHP and THP) may influence in vivo the two cellular compartments of the SEL in adult rats (i.e., proliferating/migrating neuroblasts and glial tubes). To this purpose, we have injected into the lateral ventricle P, DHP, or THP and analyzed after 2 days the SEL by immunohistochemistry by using markers for both the glial compartment (GFAP and vimentin) and the migrating neuroblasts (PSA-NCAM, Stathmin, ␤-III Tubulin); (Peretto et al., 1999) . Finally, the newly formed proliferating cells were identified and counted at the level of the OB 2 days after intraventricular injections of 5-bromo-2Ј-deoxyuridine (BrdU).
METHODS

Animals
The experiments were performed on adult male rats (300 -325 g) of Sprague-Dawley strain (Crl:CD BR; Charles River, Calco, Italy). Experimental procedures were in accordance with the institutional guidelines for animal welfare. The rats were maintained in rooms with controlled temperature (22 Ϯ 1°C) and relative humidity (60%), with a lighting schedule of 12 h of light and 12 h of darkness (light on 07.00 -19.00 h), and with standard diet and water ad libitum. To achieve the intraventricular (i.v.) injections, the rats were implanted with a guide cannula placed into the right lateral cerebral ventricle. The animals were deeply anaesthetized with pentobarbital (30 mg/kg, i.p.) and correctly positioned on a stereotaxic (Stoelting 51200). The skin of the head was cut, and the theca of the skull exposed. With a dental drill a hole was made, 1 mm posteriorly and 1 mm laterally to the bregma. A guide cannula (20-gauge), with a metallic support, was lowered into the brain to a depth of 5 mm and the correct location of the needle was verified through the flow of a minimal amount of cerebrospinal fluid. The cannula was fixed on the skull with dental cement and closed with silicone to avoid loss of cerebrospinal fluid.
Treatments
The rats were treated, 2 days after the implantation, with P, DHP, or THP. Steroids, obtained from Sigma Chemicals (Milan, Italy), were dissolved in ethanol (75% in saline). BrdU (Boehringer, Germany) was dissolved in Tris-HCl 0.1 M, pH 7.4, at the concentration of 10 mg/mL. Rats were injected with steroids (9 g/3.6 L) and with BrdU (3 L) directly into the lateral ventricle. The control group was treated with i.v. injections of BrdU (3 L) and ethanol (3.6 L-75% in saline). Forty-eight hours after the i.v. treatments, the rats were deeply anaesthetized with intraperitoneal ketamine (700 L; Ketavet; Gellini, Italy) and xylazine (200 L; Rompun; Bayer, Germany) and then intracardially perfused with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. The brains were postfixed for 12 h in the same solution, cryoprotected in ascending sucrose solutions, frozen, and cryostat-sectioned. The brains were serially sectioned in the coronal plane and free-floating sections (25 m) were collected in multiwell dishes. Series of sections representing the SEL were stored at Ϫ20°C in antifreeze solution until use.
Immunohistochemistry
For BrdU immunostaining free floating sections were treated with 2 M HCl for 1 h at 37°C and then neutralized with borate buffer, pH 8.5. Sections were incubated for 24 h at 4°C in primary antibody diluted in 0.01 M PBS, pH 7.4, 0.5% Triton X-100, 1% normal serum. For GFAP immunohistochemistry sections were incubated for 48 h at 4°C in primary antibody diluted in 0.01 M PBS, pH 7.4, 1% Triton X-100. The primary antibody dilutions were 1:150 for aBrdU (monoclonal mouse IgG; Boehringer), 1:120 for a-GFAP (monoclonal mouse IgG; Boehringer), and 1:2500 for a-PSA-NCAM (monoclonal mouse IgM; a generous gift of G. Rougon, University of Aix-Marseille, France). Sections were incubated for 1 h at room temperature in secondary biotinylated antibody (a-mouse IgG; Vector; amouse IgM; Sigma-Aldrich, Italy) diluted 1:200 in 0.01 M PBS, pH 7.4, 0.5% Triton X-100 followed by the avidinbiotin-peroxidase complex (Vector). To reveal immunoreactivity we used 0.015% 3,3Ј-diaminobenzidine, 0.0024% H 2 O 2 in 0.05 M Tris-HCl, pH 7.6. After adhesion on slides, sections were dehydrated and mounted in Sintex (Nuova Chimica, Italy).
Immunofluorescence
For immunofluorescent double labeling of BrdU and class III ␤-Tubulin, BrdU and Stathmin, or BrdU and GFAP we used monoclonal rat a-BrdU (1:1000; Harlan), rabbit a-␤-Tubulin (1:600; BABCO), rabbit a-Stathmin (1:800; a generous gift of A. Sobel, University of Paris, France), and monoclonal mouse a-GFAP (1:120 IgG; Boehringer). Sections were incubated for 48 h at 4°C in a-␤-III Tubulin, a-Stathmin, or a-GFAP primary antibody and appropriate serum and then were incubated for 1 h at room temperature in secondary antibody (Cy3 a-mouse IgGϩIgM; Jackson ImmunoResearch; Cy3 a-rabbit; Sigma) diluted 1:800. Sections were treated with 2 M HCl for 30 min at 37°C, neutralized with borate buffer pH 8.5, and incubated for 24 h at 4°C in primary a-BrdU antibody and appropriate serum. Then sections were incubated for 1 h at room temperature in secondary biotinylated antibody (a-rat IgG mouse-adsorbed; Vector) diluted 1:200 followed by avidin-FITC (Vector). Sections were mounted, air-dried, and coverslipped in polyvinyl alcohol with diazabicyclo-octane (DABCO) as an antifading agent. Fluorescent signals were detected using a FV 200 Olympus Fluoview confocal laserscanning microscope. The phenotype of BrdU-labeled cells within the SEL was analyzed in control and treated rats.
Counts of BrdU Immunoreactive Cells
A total number of 16 male rats were used (n ϭ 4 for each treatment). To evaluate the rate of cell proliferation in different experimental groups, one series of coronal sections, from the injected hemisphere, was immunohistochemically labeled for BrdU. BrdU-labeled nuclei were counted in coronal sections of the anterior SEL cut at the AOB level (Bregma level between 5.6 and 6.6 mm; Paxinos and Watson, 1982) . For each animal three coronal sections were analyzed by means of an image-analysis workstation based on an Olympus microscope, a camera (CoolSNAPPro color RS Photometrics; Media Cybernetics), and the image-analysis software Image Pro-Plus 4.1 for Windows (Copyright 1994 (Copyright , 1999 Media Cybernetics L.P.). The area of the SEL (defined as the region between the anterior olfactory nucleus, the granular layer of the main OB and the AOB) was measured and the number of BrdU-positive nuclei within the selected region was determined. The number of BrdU labeled nuclei was estimated by using a cell splitting correction factor based on the Abercrombie method (Abercrombie, 1946) 
and the formula P
where A is the number of labeled nuclei per unit area, M is the section thickness, and L is the average diameter of BrdU labeled nuclei. Cell diameters from 200 cells per group were measured. No difference in cell diameter was found between groups. Collected data were used to estimate the number of BrdU positive nuclei per mm 3 . Data were analyzed for one-way ANOVA followed by Newman-Keuls t test (NK t test).
RESULTS
Cell Proliferation and PSA-NCAM Immunoreactivity
In control animals, 2 days after a single injection of BrdU into the lateral ventricle, numerous BrdU-immunoreactive nuclei were visible through the anteriorposterior extent of the SEL, from the SEL of the lateral ventricle (SEL-LV) to the SEL of the olfactory bulb (SEL-OB). In thick (25 m) coronal sections cut at the level of the SEL-LV and SEL-RE, the labeled nuclei were densely packaged and frequently overlapped. In more anterior sections (SEL-OB) BrdUpositive nuclei were numerous but more dispersed. Only few BrdU-immunoreactive nuclei were visible through the OB layers, indicating that at 2 days postinjection virtually all the labeled proliferating/ migrating cells were still located within the SEL and had not reached the OB granular and glomerular layers (Fig. 1 ). All treatments (P, DHP, THP) apparently reduced BrdU immunostaining within the SEL-LV in the proximity of the injection site (not shown) and less robustly in more anterior regions. However, only DHP and THP induced a visible reduction of BrdU immunostaining within the whole extent of the SEL (Fig. 1) .
To evaluate the supply of newly generated cells in the OB, BrdU-labeled nuclei were counted in coronal sections of the anterior SEL from the injected hemisphere of control and treated (P, DHP, and THP) rats. Data analyzed for one-way ANOVA demonstrated a significant difference between the groups. The analysis between control and P-treated rats did not show any significant difference. Conversely, the number of BrdU-positive nuclei was significantly decreased in THP and DHP versus control and P-treated rats (NK t test, p Ͻ 0.05, Figs. 1 and 2) .
To analyze whether steroid treatment can modify the phenotypic differentiation of the newly generated (BrdU-positive) cells, we performed double labeling for BrdU and neuronal (␤ϪIII Tubulin) or glial (GFAP) markers or for BrdU and Stathmin, a marker within the SEL-OB. DHP and THP treatments strongly reduce the number of labeled nuclei in the SEL. Data are mean Ϯ standard error. *p Ͻ 0.05 compared to control and P treated rats. Ctrl, control; P, progesterone; DHP, dihydroprogesterone; THP, tetrahydroprogesterone.
of SEL migrating neuroblasts (Camoletto et al., 1997) . Our results showed that virtually all the BrdUlabeled cells within the SEL express ␤ϪIII Tubulin and Stathmin, revealing their neuronal nature, both in control and treated rats (data not shown).
Treatments did not modify the immunoreactivity for PSA-NCAM, a molecule associated in the SEL with proliferating/migrating cells (Bonfanti and Theodosis, 1994; Rousselot et al., 1995) . In all experimental groups chains of migrating cells strongly immunoreactive for the PSA-NCAM were visible within the SEL-RE (Fig. 3) . Nevertheless, in THP-treated rats, some bipolar PSA-NCAM positive cells were detected at a short distance outside the SEL-LV and SEL-RE [ Fig. 3(B) ].
SEL Astrocytes
The SEL glial compartment was studied in serial coronal sections, representative of the whole system, treated with antibodies directed against the astroglial specific marker GFAP and vimentine, an intermediate filament protein abundantly expressed by immature glial cells, such as the radial glia (Pixley and de Vellis, 1984) , and retained by astrocytes of the glial tubes (Peretto et al., , 1999 . This analysis showed that THP and, to a lesser extent, DHP treatments lead to a reduction of GFAP immunoreactivity within the SEL region, and modifications of the typical structural organization of the glial tubes. Changes induced by THP and DHP appear particularly evident at the level of the SEL-LV (not shown) and SEL-RE (Figs. 4 and 5) . After intraventricular injection of P only few modifications were found mostly restricted to the injection site. THP also reduced GFAP immunoreactivity in the parenchyma lining the SEL border (Figs. 4 and 5) . However, moving radially away from the SEL, DHP, THP, and P did not modify GFAPimmunoreactivity, suggesting that treatments principally affect the glial tubes (Figs. 4 and 5) . Frequently, in the THP-treated animals, the SEL-RE contralateral to the injection site showed similar but weaker modifications (Fig. 5) . By contrast, all the treatments apparently never modified the glial compartment within the SEL-OB.
Anti-vimentin analysis, performed in parallel sections, demonstrated the presence of vimentin-positive astrocytic processes along the SEL extent, suggesting a down-regulation of GFAP protein in this region and not a disappearance of astrocytic glial cells (not shown). Nevertheless, a partial structural disorganization of the glial tubes, namely a reduction of density of astrocytic processes, was found in THP-and DHPtreated animals (Figs. 4 and 5) . These changes of the glial compartment, particularly evident at the level of the SEL-RE, are matched with an enlargement of the SEL as shown by coronal sections stained with anti-GFAP and anti-PSA-NCAM antibodies or counterstained with cresyl violet (not shown).
DISCUSSION
In this study we have demonstrated, for the first time, that the P-derived neuroactive steroids, DHP and THP can modulate adult SEL neurogenesis. In particular, injections of THP and DHP into the lateral ventricle of the adult rat strongly reduced the number of proliferating cells within the SEL and modified some molecular and structural characteristics of the glial tubes, thus affecting both the actively proliferating and glial compartments of the SEL.
Our quantitative analysis demonstrated that the number of BrdU labeled nuclei in the anterior SEL (i.e., at the level of the AOB) is several-fold decreased in THP-and DHP-treated animals in comparison to control and P-treated animals (Fig. 2) . Such reduction of BrdU-positive nuclei in the SEL-OB can be explained by the following main reasons: (i) decreased cell division; (ii) reduced migration of neuroblasts from the posterior SEL towards the OB; (iii) reduced cell survival of proliferating labeled cells. Previous studies have demonstrated that some classes of steroid hormones (glucocorticoids and estrogens) can act on adult hippocampal neurogenesis by modulating cell proliferation (Gould et al., 1992; Cameron and Gould, 1994; Tanapat et al., 1999) . Interestingly, a recent study supplied indications for a potential regulative role of estrogens on adult SEL proliferation (Smith et al., 2001) . These overall studies, and the reduction of BrdU-positive nuclei found in our research after THP and DHP treatments, suggest that different classes of steroid hormones (glucocorticoids, estrogens, and now the p derivatives) can modulate adult neurogenesis, in the hippocampus and the SEL, by regulating the proliferative activity of progenitor cells. As far as a possible interference of DHP and THP with migratory mechanisms of the SEL neuroblasts (see above point ii) is concerned, it is important to consider that, whereas it has been demonstrated that neuroblasts continue to proliferate along their migratory pathway (Menezes et al., 1995) and neural stem cells are present until the SEL-OB (Gritti et al., 2002) , the largest number of neuroblasts migrating to the OB Figure 4 GFAP immunostaining in coronal sections cut at the same level of the SEL-RE of control (A) and treated (B,C,D) rats. Note the structural disorganization of the glial tubes and the reduction of GFAP immunoreactivity in THP-and DHP-treated rats. (E,F) Immunoreactivity for GFAP in the AON of control (E) and THP-treated (F) rats confirmed that treatments principally affect the SEL astrocytic glial compartment. Images (E) and (F) are from the same sections of images (A) and (D). Ctrl, control; P, progesterone; DHP, dihydroprogesterone; THP, tetrahydroprogesterone; SEL-RE, subependymal layer rostral extension; AON, anterior olfactory nucleus.
originate in the SEL-LV, which represents the principal source of the SEL newly formed cells. Our qualitative analysis, performed along the SEL extent, showed lack of clustered proliferating labeled cells within the caudal SEL and that THP or DHP treatment strongly reduced BrdU immunolabeling along the whole system. These results, together with the presence of "normal" PSA-NCAM immunopositive chains in treated animals, prompt us to exclude defects of the migratory mechanism. Altogether these data suggest that THP and DHP affect principally cell proliferation, rather than cell migration. Finally, we cannot exclude that the reduction of BrdU-positive nuclei, due to the THP and DHP treatments, could be related to an increase in cell death, because apoptotic cell death normally occurs along the SEL rostral migratory stream (Brunjes and Armstrong, 1996) . By contrast to P metabolites, cell proliferation in the anterior SEL is not changed in the P-treated animals. This result is in agreement with recent studies showing no clear modification of BrdU immunostaining in the SEL after subcutaneous or intraventricular injections of P (Alonso, 2000; Shingo et al., 2003) . This different behavior on SEL proliferation can be explained considering the distribution and types of receptors of P, DHP, and THP, and the enzymatic complex regulating their reciprocal interconversion. The problem of receptors involved in THP and DHP action on the SEL remains to be clarified. So far no evidence in literature demonstrates a direct action of P and its neuractive derivatives on neuroblast proliferation. Moreover, it is unknown whether these cells express the P receptor (PR). On the other hand, it is important to highlight that while DHP, like P itself, is able to bind to the PR, THP represents a potent ligand of the GABA A receptor (Melcangi et al., 1999 (Melcangi et al., , 2001a . A potential involvement of the GABA A receptor in our system is suggested by some developmental studies. Neuronal progenitors of the postnatal rat subventricular zone (SVZ), namely the SEL precursor region, express functional GABA A receptors (Stewart et al., 2002) and GABA decreases cell proliferation in the embryonic SVZ (Haydar et al., 2000) . These data support the hypothesis that THP may act directly on neuroblast proliferation by activation of the GABA A receptor. Considering THP as being responsible for the effect on neuroblast proliferation, the effect exerted by DHP might be ascribed to its conversion into THP by the action of the 3␣-HSD enzyme. This hypothesis might be strengthened by our previous observations indicating that considerable levels of enzymatic activities converting steroid hormones into neuroactive steroids are also present in undifferentiated cells, such as stem cells originating from the mouse striatum (Melcangi et al., 1996a) . Thus, the lack of effect on proliferation following P injection could be due to the absence of PR in the actively proliferating cells, or to the time course necessary for the conversion of P into DHP and subsequently into THP. Previous studies have demonstrated that, in normal conditions, the newly formed cells of the SEL express class III ␤-Tubulin, a marker for young neurons (Doetsch and Alvarez-Buylla, 1996; Jankovski and Sotelo, 1996; Peretto et al., 1997) , and differentiate into OB local interneurons (Luskin, 1993; Lois and Alvarez-Buylla, 1994) . However, in vitro experiments have demonstrated that the SEL contains multipotent neural stem cells able to give rise to both neurons and glia (Morshead et al., 1994; Gritti et al., 2002) . Moreover, i.v. injections of epidermal growth factor can induce glial differentiation of SEL progenitors in vivo (Craig et al., 1996; Kuhn et al., 1997) . Thus, to ascertain whether p derivatives can induce a shift in phenotypic differentiation of the proliferating cells, we examined the expression of neuronal and glial markers by newly generated cells. Our results indicate that virtually all the BrdU-labeled cells, within the SEL, colocalize with class III ␤-Tubulin and the SEL neuroblasts marker Stathmin both in control and treated rats, indicating that THP and DHP do not affect the fate of newborn cells.
Recently, it has been demonstrated that cortical lesions and strokes affect adult neurogenesis by inducing cell proliferation within the SEL and/or migration of newly generated cells into the damaged area (Magavi et al., 2000; Jin et al., 2001; Arvidsson et al., 2002) . These data suggest that i.v. injections, widely used to study the behavior of the SEL proliferating neuroblasts (Lois and Alvarez-Buylla, 1994; Craig et al., 1996; Kuhn et al., 1997) , might modify neurogenesis in the SEL region. Nevertheless, the reduction of BrdU-positive nuclei, observed in the SEL-OB of THP-and DHP-treated rats, must be principally determined by steroid treatments because both control and treated animals were injected in the lateral ventricle and we analyzed the SEL-RE and SEL-OB several millimeters far from the injection site.
It is important to note that our data also indicate that neuroactive derivatives of P influence the SEL glial compartment. THP, DHP, and P, although with different intensity, act on glial tubes, modifying their organization and decreasing GFAP-immunoreactivity in SEL astrocytes. Structural changes of the glial tubes can explain the presence, outside the SEL-RE of THP-treated rats (see Fig. 3 ), of PSA-NCAM-immunoreactive cells that may represent ectopic migrating neuroblasts. An effect of neuroactive steroids on glial cells is not surprising because they express both classical (i.e., PR) and nonclassical (i.e., GABA A ) steroid receptors and consequently this cellular compartment is now considered a target for these molecules (Melcangi et al., 2001b) . In this context, it is important to remember that, in agreement with the present in vivo observations, we have observed that DHP and THP down-regulate GFAP gene expression in culture of protoplasmic astrocytes (Melcangi et al., 1996b) . Consequently, because astrocytes express both PR and GABA A receptor (Melcangi et al., 2001b) , the effects exerted by HP and THP in vivo might be ascribed to interaction with PR, or with GABA A receptor, or to a mixed action. To this purpose, future experiments will be required to explain the receptors involved in such effects.
Finally, considering the putative importance of the glial cells in this cellular system, it is also possible to hypothesize that the effects exerted by neuroactive steroids on neuroblast proliferation might also be a consequence of impaired function of the glial compartment (e.g., reduced release of neurogenetic factors). Indeed, many different studies are now focusing on the importance of astrocytic glial cells of this system that show very particular molecular characteristics and can actually provide the stem cell niche and stem cell reservoir of the SEL (Doetsch et al., 1999; Lim et al., 2000; Peretto et al., 2002) .
